BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 15, 2016
View Archived Issues
Alpine Immune Sciences announces USD 48 million series A financing
Read More
EnBiotix signs deal with Mayo Clinic to continue development of EPP-001
Read More
Regen BioPharma identifies small molecules that activate NR2F6
Read More
Marathon Pharmaceuticals submits NDA to FDA for deflazacort in DMD
Read More
Shire signs global rights agreement with Pfizer for PF-00547659
Read More
Promising activity seen in colorectal cancer study with encorafenib, cetuximab and alpelisib
Read More
Janssen BACE inhibitor studied for Alzheimer's in asymptomatic subjects
Read More
Novartis patents complement factor D inhibitors
Read More
The Medicines Company doses first patient in phase II trial of ABP-700
Read More
PharmaMar starts trial for plitidepsin in patients with T-cell lymphoma
Read More
GlaxoSmithKline discloses CD38 inhibitors
Read More
Merck & Co. describes BACE 1/2 inhibitors
Read More
Takeda Pharmaceutical develops ACC1 inhibitors
Read More
Advanced Proteome Therapeutics annnounces partnership with Heidelberg Pharma
Read More
New ADC IMGN-632 shows promising preclinical results in AML
Read More
Phase I/II study finds encouraging survival with VAL-083 in recurrent glioblastoma
Read More
[18F]FTP2, a novel PET probe to detect gefitinib-resistant tumors
Read More
PRX-003: first-in-human data
Read More
Sirukumab: data from SIRROUND-D
Read More
twoXAR completes preclinical studies to evaluate rheumatoid arthritis candidates
Read More
Topline results from phase II study of duvelisib in refractory indolent NHL
Read More
Mesoblast regains rights to mesenchymal precursor cell technology platform
Read More
Vicore completes first-in-human study of C-21
Read More
